October Fertility Market Update: Two New Developments Illustrate Continuing Challenges For Fertility

Conceivex’s Conception Kit At-Home System Is FDA Cleared New First
Step Infertility Treatment

BLOOMFIELD HILLS, Mich.–(BUSINESS WIRE)–#ASRM2016–Fertility challenges continue for couples who want to start a family
today, as highlighted by two recent developments:

• A new study found that 18- to 22-year-old men who were conceived
  through a common type of in vitro fertilization (IVF) had almost half
  the sperm concentration and a two-fold lower total sperm count and
  total count of motile sperm that could swim well compared to men their
  age that had been conceived naturally. This study focused on 54 men
  who were conceived via intracytoplasmic sperm injection (ICSI), a
  technique developed in the 1990s to treat cases when infertility is
  tied to the male. Study co-author, Andre Van Steirteghem of the Center
  for Reproductive Medicine at the University Hospital of Vrije
  University in Brussels, noted that, “This study indicates that ICSI
  done for severe male factor infertility may lead to the same condition
  [in male offspring] as the one in the father.”
• In September, the magazine New Scientist reported that a boy
  born five months earlier had been conceived using the DNA from three
  people, one male and two females. This “three parent process” enabled
  the avoidance of a rare genetic mutation carried by one of the females
  in this case. The same magazine reported earlier this month that two
  women in Ukraine are currently pregnant with children conceived via
  the “three parent process” that was used, in these cases, to treat
  infertility.

“Couples who want to start a family today face a more complex
environment and higher costs,” Michael
La Vean, President and Founder of Conceivex, maker of The
Conception Kit® at-home system, said. “Fortunately, there now is an
insurance-covered, at home, alternative that couples can use as their
first step to overcome infertility. Previously, couples either had to
continue to struggle or move directly to more expensive and invasive
treatments since that first step never existed.”

The Conception Kit is an FDA cleared, drug- and hormone-free infertility
treatment that couples can get with a prescription for a $30-$75 co-pay
(under many insurance plans). About 60 percent of insured individuals in
the U.S. already have reimbursable access to the Conception Kit through
their pharma benefits manager (including Express Scripts, CVS/Caremark,
and others) and it is available at more than 65,000 pharmacies in the
U.S., including Walmart, Target, Walgreens, and Rite Aid.

The FDA required clinical trials on placement of the Conception Kit’s
Conception Cap (a cervical cap that is used for insemination at home)
and instructions by patients. During the trials, 24 percent of the
patients got pregnant during the first 30 days.

By comparison, many historic infertility treatment options can prove
costly. For example, a single cycle of IVF costs $12,500 on average,
according to the American Society for Reproductive Medicine, and is not
always covered by insurance. And while advancements have been made in
IVF treatment, patients who elect this route to address infertility
still face risks, including multiple births as well as premature births
that can land newborns in the Neonatal Intensive Care Unit (NICU), and
thereby drive up overall healthcare costs.

The
Conception Kit provides three months of supplies (including 24
ovulation predictors, three pregnancy tests, along with the Conception
Cap, and a number of additional proprietary aides) – that, in many
cases, would cost more over-the-counter than the total amount of the
co-pay. Even without a co-pay, the entire Conception Kit is available
for $360.

About
Conceivex, Inc.

Conceivex, Inc., manufactures and distributes The
Conception Kit® at-home system, a safe, effective, FDA cleared, and
reasonably priced healthcare product that helps couples overcome
infertility at home. The Conception Kit, which is covered by many
insurance plans (including Express Scripts and CVS/Caremark), is
obtainable with a prescription at Walmart, Target, Walgreens, Rite Aid,
and 65,000 pharmacies nationwide. Find out more at www.conceptionkit.com,
on Facebook at https://www.facebook.com/conceptionkit/,
on LinkedIn,
and on Twitter (@conceptionkit).

Contacts

Montgomery Strategies
Michael W. Robinson, 202-255-0737
Mrobinson@tmsgr.com
PA
26-2016